MEFV |
IPI00375378 |
CASP5 |
CASP5, ICH3: Caspase-5 precursor |
2.622 |
Evidence |
|
TCF3 |
IPI00216911 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
2.622 |
Evidence |
|
DEDD2 |
DEDD2, FLAME3, PSEC0004: DNA-binding death effector domain-containing protein 2 |
ANK1 |
IPI00297532 |
2.622 |
Evidence |
|
HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-G |
HLA-G, DAQB-346J13.1-002, DASS-366B6.2-002, XXbac-BCX209H21.15-002, XXbac-BPG12I |
2.622 |
Evidence |
|
ZNF271 |
IPI00031623 |
ZNF287 |
ZNF287, ZKSCAN13: Zinc finger protein 287 |
2.622 |
Evidence |
|
HLA-DQA1 |
HLA class II histocompatibility antigen, DQ(W3) alpha chain precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
2.622 |
Evidence |
|
NALP5 |
NLRP5, MATER, NALP5: NACHT, LRR and PYD domains-containing protein 5 |
NFKB2 |
IPI00477537 |
2.622 |
Evidence |
|
BLNK |
IPI00718885 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
2.622 |
Evidence |
|
BCL2L11 |
BCL2L11, BIM: Bcl-2-like protein 11 |
BCL2L12 |
BCL2L12, BPR: Bcl-2-related proline-rich protein |
2.622 |
Evidence |
|
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
NULL |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-38 alpha chain precursor |
2.622 |
Evidence |
|
BMF |
BMF: Bcl-2-modifying factor |
BOK |
BOK: Bcl-2-related ovarian killer protein |
2.622 |
Evidence |
|
TCF3 |
IPI00216911 |
MXD1 |
MXD1, MAD: MAD protein |
2.622 |
Evidence |
|
BHLHB8 |
BHLHB8, MIST1: Class B basic helix-loop-helix protein 8 |
PHTF1 |
PHTF1, PHTF: Putative homeodomain transcription factor 1 |
2.622 |
Evidence |
|
MYF5 |
MYF5: Myogenic factor 5 |
TCF3 |
IPI00216911 |
2.622 |
Evidence |
|
TAP1 |
IPI00101026 |
ABCD2 |
ABCD2, ALD1, ALDL1, ALDR, ALDRP: ATP-binding cassette sub-family D member 2 |
2.622 |
Evidence |
|
HCN1 |
HCN1, BCNG1: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gate |
CACNA1D |
CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2: Voltage-dependent L-type calcium chann |
2.622 |
Evidence |
|
KCNQ1 |
KCNQ1, KCNA8, KCNA9, KVLQT1: Potassium voltage-gated channel subfamily KQT membe |
CACNA1F |
CACNA1F: Uncharacterized protein CACNA1F |
2.622 |
Evidence |
|
BHLHB3 |
BHLHB3, DEC2, SHARP1: Class B basic helix-loop-helix protein 3 |
MYCL1 |
MYCL1, LMYC, MYCL: L-myc-1 proto-oncogene protein |
2.622 |
Evidence |
|
MEFV |
IPI00375378 |
NALP5 |
NLRP5, MATER, NALP5: NACHT, LRR and PYD domains-containing protein 5 |
2.622 |
Evidence |
|
NULL |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-33 alpha chain precursor |
CD1E |
CD1E, RP11-101J8.5-005, hCG_1640053: CD1e molecule |
2.622 |
Evidence |
|
BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
BCL2L14 |
BCL2L14, BCLG: Apoptosis facilitator Bcl-2-like 14 protein |
2.622 |
Evidence |
|
GABRA1 |
GABRA1: Gamma-aminobutyric acid receptor subunit alpha-1 precursor |
GABRA4 |
GABRA4: Gamma-aminobutyric acid receptor subunit alpha-4 precursor |
2.622 |
Evidence |
|
LARS2 |
LARS2, KIAA0028: Probable leucyl-tRNA synthetase, mitochondrial precursor |
PLXNB2 |
MM1: Clone MM1 product (Fragment) |
2.622 |
Evidence |
|
FES |
FES, FPS: Proto-oncogene tyrosine-protein kinase Fes/Fps |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
2.622 |
Evidence |
|
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
NULL |
MHC class II HLA-SX-alpha gene. (Fragment) |
2.622 |
Evidence |
|